Vivanza -Drug Insights, 2016 Now Available at iData Insights
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5.1 United St<strong>at</strong>es<br />
5.2 Europe<br />
6 P<strong>at</strong>ent Inform<strong>at</strong>ion<br />
6.1 P<strong>at</strong>ent Numbers and Expiry Details<br />
6.2 P<strong>at</strong>ent and Exclusivity Expiry Assessment United St<strong>at</strong>es (US)<br />
6.3 P<strong>at</strong>ent Details<br />
7 Route of Synthesis<br />
8 Global API Manufacturers Assessment<br />
8.1 The United St<strong>at</strong>es <strong>Drug</strong> Master File (US DMF)<br />
8.2 The Europe <strong>Drug</strong> Master File (EUDMF)/Active Substance Master File (ASMF)<br />
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China<br />
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India<br />
9 Generic Players<br />
10 The Pipeline Coverage<br />
11 Clinical Trials Inform<strong>at</strong>ion<br />
11.1 Clinical Trials by Zone<br />
12 Company Profile<br />
12.1 Company Summary<br />
12.2 Company Financials<br />
13 SWOT Analysis<br />
14 References<br />
15 Appendix<br />
16 Methodology<br />
2
Change language